162050-73-9 Usage
Uses
Used in Pharmaceutical Industry:
Dexibuprofen is used as an analgesic and anti-inflammatory agent for the treatment of conditions such as osteoarthritis and rheumatoid arthritis. Its effectiveness in alleviating pain and reducing inflammation is attributed to its ability to inhibit the production of certain chemicals involved in the inflammation process.
Used in Pain Management:
Dexibuprofen is utilized as a pain management agent, providing relief from mild to moderate pain. Its analgesic properties make it a suitable option for patients seeking to manage pain associated with various conditions.
Used in Inflammation Reduction:
Dexibuprofen is employed as an inflammation reduction agent, targeting the chemicals responsible for inflammation and helping to minimize its effects on the body. This application is particularly beneficial for individuals suffering from conditions characterized by chronic inflammation, such as arthritis.
Administered in Various Forms:
Dexibuprofen is available in different forms, including tablets, capsules, and oral suspension, allowing for flexible and convenient administration options. It is typically taken orally, and it is crucial to follow the guidance of a healthcare professional to ensure safe and effective use, minimizing the risk of adverse effects.
Check Digit Verification of cas no
The CAS Registry Mumber 162050-73-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,0,5 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 162050-73:
(8*1)+(7*6)+(6*2)+(5*0)+(4*5)+(3*0)+(2*7)+(1*3)=99
99 % 10 = 9
So 162050-73-9 is a valid CAS Registry Number.
162050-73-9Relevant academic research and scientific papers
Synthesis of chiral nonracemic tertiary α-thio and α-sulfonyl acetic esters via SN2 reactions of tertiary mesylates
Weaver, Jimmie D.,Morris, David K.,Tunge, Jon A.
scheme or table, p. 470 - 474 (2010/04/29)
Syntheses of enantioenriched sulfides and sulfones via substitution of tertiary mesylate with thiolate nucleophile were achieved with modest to excellent success. Georg Thieme Verlag Stuttgart New York.
